Jens D Lundgren Selected Research

Monoclonal Antibodies

1/2022	Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
1/2022	Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery.
11/2021	A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
1/2021	Monoclonal Antibody for Patients with Covid-19. Reply.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jens D Lundgren Research Topics

Disease

37	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 01/2002
30	Infections 01/2022 - 07/2002
21	HIV Infections (HIV Infection) 08/2016 - 08/2002
19	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2003
14	Neoplasms (Cancer) 01/2021 - 06/2004
14	Inflammation (Inflammations) 10/2020 - 05/2002
11	Disease Progression 01/2021 - 01/2002
11	Coinfection 12/2020 - 03/2005
10	Myocardial Infarction 01/2018 - 11/2003
9	COVID-19 01/2022 - 10/2020
8	Critical Illness (Critically Ill) 01/2019 - 07/2008
8	Hepatitis B 07/2014 - 03/2005
6	Diabetes Mellitus 12/2020 - 05/2003
6	Sepsis (Septicemia) 01/2019 - 08/2007
6	Hepatitis 01/2016 - 12/2008
6	Hypertension (High Blood Pressure) 03/2015 - 05/2003
5	Tuberculosis (Tuberculoses) 01/2021 - 04/2005
5	Hepatitis C 03/2015 - 01/2005
4	Liver Cirrhosis (Hepatic Cirrhosis) 07/2014 - 01/2011
4	Hypersensitivity (Allergy) 01/2011 - 09/2003
4	Coronary Disease (Coronary Heart Disease) 02/2009 - 05/2003
4	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 01/2008 - 08/2004
3	Stroke (Strokes) 08/2019 - 01/2013
3	Septic Shock (Toxic Shock Syndrome) 01/2019 - 01/2015
3	Bacterial Infections (Bacterial Infection) 01/2017 - 01/2008
3	Chronic Renal Insufficiency 01/2017 - 07/2010
3	Fibrosis (Cirrhosis) 06/2015 - 01/2014
3	Thrombocytopenia (Thrombopenia) 01/2013 - 01/2013
3	Insulin Resistance 10/2012 - 12/2007
3	Lipodystrophy 10/2012 - 05/2003
3	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 09/2010 - 07/2002
3	Leukocytosis (Pleocytosis) 04/2006 - 08/2004
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 03/2016
2	Neural Tube Defects (Exencephaly) 01/2020 - 02/2019
2	Cytomegalovirus Infections (Inclusion Disease) 06/2019 - 05/2011
2	Alcoholism (Alcohol Abuse) 01/2019 - 03/2014
2	Respiratory Insufficiency (Respiratory Failure) 01/2018 - 12/2016
2	Pneumonia (Pneumonitis) 01/2018 - 09/2008
2	Viremia 02/2014 - 08/2009
2	Lung Neoplasms (Lung Cancer) 10/2013 - 11/2010
2	Anus Neoplasms (Anal Cancer) 01/2013 - 11/2010
2	Dyslipidemias (Dyslipidemia) 10/2012 - 04/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2011 - 03/2009
2	Pancreatitis 05/2008 - 01/2008

Drug/Important Bio-Agent (IBA)

26	Pharmaceutical PreparationsIBA 01/2022 - 07/2002
16	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2006
13	RNA (Ribonucleic Acid)IBA 12/2020 - 05/2003
9	Interleukin-6 (Interleukin 6)IBA 09/2020 - 06/2013
9	C-Reactive ProteinIBA 09/2020 - 07/2008
8	Protease Inhibitors (Protease Inhibitor)IBA 01/2018 - 01/2005
7	Anti-HIV Agents (AIDS Drugs)IBA 08/2019 - 02/2009
7	Reverse Transcriptase InhibitorsIBA 01/2018 - 01/2005
7	fibrin fragment D (D-dimer)IBA 01/2017 - 06/2013
7	insulin receptor-related receptor (IRR)IBA 01/2012 - 03/2005
6	ProcalcitoninIBA 03/2018 - 08/2007
6	abacavir (Ziagen)FDA Link 01/2018 - 10/2004
6	CholesterolIBA 01/2014 - 05/2003
6	Triglycerides (Triacylglycerol)IBA 09/2011 - 11/2003
5	Ritonavir (Norvir)FDA Link 01/2018 - 11/2005
5	NucleosidesIBA 01/2018 - 01/2005
5	Anti-Bacterial Agents (Antibiotics)IBA 03/2015 - 08/2004
5	Hyaluronic Acid (Hyaluronan)IBA 07/2014 - 01/2011
5	HDL CholesterolIBA 01/2014 - 12/2007
4	Antiviral Agents (Antivirals)IBA 01/2022 - 06/2015
4	Monoclonal AntibodiesIBA 01/2022 - 01/2021
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 10/2020
3	BilirubinIBA 01/2019 - 09/2011
3	Atazanavir Sulfate (Reyataz)FDA Link 01/2018 - 01/2013
3	LipidsIBA 01/2016 - 05/2003
3	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 03/2015 - 01/2012
3	Stavudine (Zerit)FDA LinkGeneric 04/2008 - 01/2008
3	Hemoglobins (Hemoglobin)IBA 01/2003 - 01/2002
2	remdesivirIBA 01/2022 - 11/2021
2	VaccinesIBA 01/2022 - 04/2021
2	AntigensIBA 01/2022 - 04/2005
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2022 - 10/2020
2	bamlanivimabIBA 01/2022 - 11/2021
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021 - 11/2009
2	CytokinesIBA 09/2020 - 07/2019
2	dolutegravirIBA 01/2020 - 02/2019
2	6-chloropenicillanic acid S-sulfoxideIBA 01/2018 - 01/2015
2	CreatinineIBA 01/2017 - 07/2010
2	Lopinavir FDA Link 01/2016 - 01/2011
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2015 - 03/2005
2	Ciprofloxacin (Cipro)FDA LinkGeneric 03/2015 - 01/2013
2	Cefuroxime (Zinacef)FDA LinkGeneric 03/2015 - 01/2013
2	Zidovudine (Retrovir)FDA LinkGeneric 07/2014 - 04/2008
2	Vitamin D FDA LinkGeneric 07/2014 - 06/2011
2	hydroxide ionIBA 07/2014 - 06/2011
2	Indicators and Reagents (Reagents)IBA 01/2013 - 01/2008
2	Didanosine (Videx)FDA LinkGeneric 04/2008 - 01/2008

Therapy/Procedure

43	Therapeutics 01/2022 - 08/2002
17	Highly Active Antiretroviral Therapy (HAART) 10/2012 - 01/2002
13	Art Therapy 01/2021 - 01/2008
4	Transplantation 12/2019 - 05/2011
4	Critical Care (Surgical Intensive Care) 01/2019 - 01/2012
2	Organ Transplantation 01/2020 - 05/2011
2	Artificial Respiration (Mechanical Ventilation) 01/2019 - 01/2018
2	Mechanical Ventilators (Ventilator) 01/2018 - 12/2016
2	Induced Hypothermia 01/2018 - 01/2015